{
    "clinical_study": {
        "@rank": "46761", 
        "arm_group": [
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "5% dextrose infusion for 72 hours during ventilator care start within 48 hours after birth"
            }, 
            {
                "arm_group_label": "remifentanil", 
                "arm_group_type": "Active Comparator", 
                "description": "0.1mcg/kg/min remifentanil infusion for 72 hours during ventilator care start within 48 hours after birth"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate efficacy of remifentanil in preterm infants during\n      ventilator care with remifentanil and to analyze pharmacokinetics in preterm infants"
        }, 
        "brief_title": "Remifentanil in Ventilated Preterm Infants", 
        "completion_date": {
            "#text": "February 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Preterm Infants", 
            "Mechanical Ventilator Care"
        ], 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  preterm infants (<37weeks of gestational age)\n\n          -  requiring ventilator care\n\n          -  informed consent\n\n        Exclusion Criteria:\n\n          -  major anomaly\n\n          -  48hrs after birth\n\n          -  requiring operation during drug infusion\n\n          -  cord blood pH < 7.0\n\n          -  intraventricular hemorrhage grade III or more\n\n          -  investigators decision"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "48 Hours", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "41", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 31, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01713127", 
            "org_study_id": "RFTN-02", 
            "secondary_id": "12077"
        }, 
        "intervention": [
            {
                "arm_group_label": "remifentanil", 
                "intervention_name": "remifentanil infusion", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Remifentanil"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "October 26, 2012", 
        "location": {
            "contact": {
                "email": "kimhans@snu.ac.kr", 
                "last_name": "Han-Suk Kim, MD, PhD", 
                "phone": "82-2-2072-1696"
            }, 
            "contact_backup": {
                "email": "revival421@snu.ac.kr", 
                "last_name": "Seung Han Shin, MD", 
                "phone": "82-2-2072-0647"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "110-744"
                }, 
                "name": "Seoul National University Children's Hospital"
            }, 
            "investigator": {
                "last_name": "Han-Suk Kim Kim, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Efficacy and Safety of Remifentanil in Preterm Infants Who Require Ventilator Support", 
        "overall_contact": {
            "email": "kimhans@snu.ac.kr", 
            "last_name": "Han-Suk Kim, MD,PhD", 
            "phone": "82-2-2072-1696"
        }, 
        "overall_contact_backup": {
            "email": "revival421@snu.ac.kr", 
            "last_name": "Seung Han Shin, MD", 
            "phone": "82-2-2072-0647"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Korea: Food and Drug Administration", 
                "Korea: Institutional Review Board"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "February 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "PIPP measure during tracheal suction window period ; +/- 1hr", 
            "measure": "premature infant pain profile (PIPP)", 
            "safety_issue": "No", 
            "time_frame": "24hours after remifentanil/placebo infusion"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01713127"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "intraventricular hemorrhage documented by sonography", 
                "measure": "intraventricular hemorrhage", 
                "safety_issue": "No", 
                "time_frame": "up to 1 week of age"
            }, 
            {
                "description": "pneumothorax documented by X-ray or sonography", 
                "measure": "pneumothorax", 
                "safety_issue": "No", 
                "time_frame": "up to 1 week of age"
            }, 
            {
                "description": "O2 dependency", 
                "measure": "bronchopulmonary dysplasia", 
                "safety_issue": "No", 
                "time_frame": "28 days of age"
            }, 
            {
                "description": "mechanical ventilator dependency", 
                "measure": "duration of ventilator care", 
                "safety_issue": "No", 
                "time_frame": "up to 4 months of age"
            }, 
            {
                "description": "days from admission to discharge from neonatal intensive care unit", 
                "measure": "hospital day", 
                "safety_issue": "No", 
                "time_frame": "upto 4 months of age"
            }, 
            {
                "description": "day of life when the baby reaches full enteral feeding, defined as a volume above 120 mL/kg/day", 
                "measure": "time to full feeding", 
                "safety_issue": "No", 
                "time_frame": "up to 2 months of age"
            }, 
            {
                "description": "in-hospital death", 
                "measure": "mortality", 
                "safety_issue": "No", 
                "time_frame": "up to 4 months of age"
            }, 
            {
                "description": "category of adverse effects\nGeneral appearance Fever or Hypothermia, Rash\nRespiratory & Cardiovascular Arrhythmia Tachypnea (RR >100/min) Desaturation (SpO2 <80%) Hypotension (inotropics use or need volume challenge) Bradycardia (HR <80/min) Tachycardia (HR >200/min)\nGastrointestinal Abdominal distension Bilious gastric remain Vomiting Bloody Stool Necrotizing Enterocolitis\nRenal  Oliguria (U/O < 1.0cc/kg/day)\nNeurologic Seizure Cerebral infarction", 
                "measure": "development of adverse effects", 
                "safety_issue": "Yes", 
                "time_frame": "from the start of remifentanil infusion to 1 hour after end of infusion"
            }
        ], 
        "source": "Seoul National University Hospital", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Ajou University School of Medicine", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "DongGuk University", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Seoul National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "October 2012"
    }
}